Interacting Drugs |
Paclitaxel vs Reverse Transcriptase Inhibitors (Non-Nucleoside) |
Security Level |
|
Mechanism |
Reverse Transcriptase Inhibitors (Non-Nucleoside): May decrease the metabolism of PACLitaxel. |
Management |
Monitor therapy |
Paclitaxel vs Reverse Transcriptase Inhibitors (Non-Nucleoside)
Post Review about Paclitaxel vs Reverse Transcriptase Inhibitors (Non-Nucleoside) Click here to cancel reply.
Other Interactions of Paclitaxel
Other Interactions of Reverse Transcriptase Inhibitors (Non-Nucleoside)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.